Cargando…
Modeling and multiscale characterization of the quantitative imaging based fibrosis index reveals pathophysiological, transcriptome and proteomic correlates of lung fibrosis induced by fractionated irradiation
Pulmonary fibrosis represents a leading cause of morbidity and mortality worldwide. Therapy induced lung fibrosis constitutes a pivotal dose‐limiting side effect of radiotherapy and other anticancer agents. We aimed to develop objective criteria for assessment of fibrosis and discover pathophysiolog...
Autores principales: | Zhou, Cheng, Moustafa, Mahmoud R., Cao, Liji, Kriegsmann, Mark, Winter, Martin, Schwager, Christian, Jones, Bleddyn, Wang, Shijun, Bäuerle, Tobias, Zhou, Ping‐Kun, Schnölzer, Martina, Weichert, Wilko, Debus, Juergen, Abdollahi, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590477/ https://www.ncbi.nlm.nih.gov/pubmed/30536712 http://dx.doi.org/10.1002/ijc.32059 |
Ejemplares similares
-
Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model
por: Zhou, Cheng, et al.
Publicado: (2018) -
Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model
por: Zhou, Cheng, et al.
Publicado: (2017) -
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China Study
por: Wu, Yi‐Long, et al.
Publicado: (2020) -
Laser therapy as a treatment for chronic radiation fibrosis
por: Wilson, Britney, et al.
Publicado: (2022) -
A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study
por: Unseld, Matthias, et al.
Publicado: (2020)